Archives: Speakers

Anne McPhee, SVP Global Asset Development and Operations at Worley Consulting, is an experienced leader with a deep knowledge of global energy, fuels, and chemicals markets grounded in a strong technology background. She is committed to working with our customers clients to optimize strategic decision making and to drive asset and operations transformation while navigating rapidly changing markets.

Steve held senior managements position with both asset owners and consultancy organizations and now leads initiatives within multiple major utilities to transform asset and operations management, including the design and implementation of new structures, decision making frameworks, policy and governance frameworks to increase organisational capability, as well as managing the necessary business change/transformation.

Clayton Ludik is the Vice President of Digital Consulting at Worley, leading a team of 150 specialists driving digital and automation modernization and transformation across industrial operating assets. With two decades of experience in engineering, R&D, and technology modernisation, Clayton brings a practical, ROI-focused approach to helping clients realise their ‘asset of the future’ aspirations.

Dr. Erin (Meyer) Goodhue, DO, MPH, is Director of Transfusion and Apheresis Services at The Ohio State University Wexner Medical Center. She brings 20+ years of leadership across academic medicine, pediatric care, industry, and global research. Prior to her current role, Dr. Goodhue served as Director of Global Clinical Research at Terumo BCT and held clinical leadership roles at Nationwide Children’s Hospital and the American Red Cross. She earned her DO from the University of New England, an MPH from Dartmouth, and completed faculty appointments at Harvard, Emory, and Dartmouth.

Dr. Kate Rochlin has served as IN8bio’s Chief Operating Officer since December 2021 and previously as their VP, Operations and Innovation. She has 19+ years of expertise in strategic company development & operations, IP, CMC, and Clinical manufacturing of advanced therapies. She was previously the Chief Business Officer at Curadigm, a Cambridge-based spin-out of Nanobiotix focused on RNA therapeutic bioavailability. Prior, Dr. Rochlin co-founded and served as CSO at Immunovent in New York City. Dr. Rochlin earned a Ph.D. in Molecular Biology and Genetics from Weill Cornell Medical College, researched at Sloan Kettering Institute, and a BA from the University of Pennsylvania.

Dr. Ortega holds a doctorate in Molecular Biology and Analytical Chemistry from the University of Hawaii at Manoa. With a strong background in mass spectrometry, she serves as the Associate Director of Analytical Services at TriLink Biotechnologies. As part of the Analytical Development team, Dr. Ortega specializes in the physicochemical analysis of mRNA, oligonucleotides (i.e. gRNA), and small molecules such as NTPs and CleanCap® analogs. Her commitment to analytical excellence, combined with her scientific expertise, drives the development of robust methodologies to effectively fulfill client analytical requests and expand TriLink’s portfolio of analytical testing services.

Dr. Cody Palumbo is a Senior Application Scientist in Technical Design at TriLink BioTechnologies, where he partners with customers to support gRNA, oligonucleotide, and gene editing workflows by providing technical guidance and customized solutions. He brings deep expertise in CRISPR-based technologies and therapeutic development, drawing on years of experience across biotech and pharmaceutical settings. Prior to TriLink, Dr. Palumbo served as Associate Director of Gene Editing Process Development and Tech Transfer at Sana Biotechnology and led a team of Process Development scientists at Bristol Myers Squibb focused on gene editing tools for cell therapies. He holds a Ph.D. in Chemistry from the University of California, Davis. Dr. Palumbo is passionate about bridging technical innovation with real-world impact and frequently speaks on the evolving landscape of genome editing technologies.

Beatriz Valle trabaja en el equipo de Tecnología y Servicios Empresariales (ETS) de GlobalData. Su función consiste en el análisis competitivo de las tendencias tecnológicas en torno a los centros de datos y las tecnologías de inteligencia artificial, con especial atención a la IA generativa, sus productos y servicios. Valle ha sido analista del sector desde 2006, trabajando para varias empresas globales y cuenta con experiencia en consultoría. Ha sido citada en numerosas publicaciones financieras y comerciales, como Reuters, Forbes, Computing, The Register, DataCenterDynamics, DataCenter Knowledge, Network World, Futurism, Tech Monitor, Wired, etc.

NIKEN PRAWESTI has embarked on her journey in the hospitality industry 15 years ago. Skilled in negotiation, business planning, and leadership, she founded and led Liberta Hotel International (LHI), a hotel management company focused on lifestyle hospitality since 2020. Her expertise lies in leveraging data-driven insights to craft targeted and innovative business solutions. Since its establishment, LHI has managed hotels and F&B establishments around Indonesia, transforming hospitality industry into a more dynamic and technology-driven one. Niken has also been an active contributor to the World Bank since 2017, specializing in Women, Business, and the Law Practice group. In her free time, she enjoys reading and golf.